Endogena

Endogena Therapeutics

This biotech company develops small-molecule regenerative medicines to repair tissues and organs for patients with degenerative eye diseases and genetic disorders.

Endogenous

This company develops small-molecule drugs that activate a patient's own stem cells to repair tissues for treating degenerative diseases.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.

Rejuveron Life Sciences AG

This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.

Atsena Therapeutics

This clinical-stage company develops gene therapies to treat and prevent inherited retinal diseases for patients with conditions such as X-linked retinoschisis and Stargardt disease.